RNAway
PrivateLast Round
Seed
Jan 1, 2022
Company Overview
RNAway is an agricultural technology company that develops and markets a patented platform technology for delivering RNA molecules into plants via spray or irrigation for crop protection and trait modification.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RNAway Comparables
Compare RNAway with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CDotBio | 89% | |
| Agriterna | 86% | |
| Terrana Biosciences | 84% | |
RNAway Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 1, 2022 |
Key People
Founding team and executive leadership
RNAway Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Copia Agro & Food | Seed |
RNAway Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RNAway's valuation, stock price, and market status.